NCT00042653 - A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis | Biotech Hunter

Enrollment

380

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions

Secondary HyperparathyroidismEnd Stage Renal Disease

Interventions

DRUG

Placebo

30 mg of placebo taken once daily orally 60 mg of placebo taken once daily orally 90 mg of placebo taken once daily orally 120 mg of placebo taken once daily orally 180 mg of placebo taken once daily orally

DRUG

AMG 073

30 mg of AMG 073 taken once daily orally 60 mg of AMG 073 taken once daily orally 90 mg of AMG 073 taken once daily orally 120 mg of AMG 073 taken once daily orally 180 mg of AMG 073 taken once daily orally